Archive

HIGHLIGHTS

 
EQT Life Sciences leads $42M funding round in Phagenesis
Phagenesis, a medical devices company, which specializes in the treatment of swallowing disorders, successfully closes a $42M Series D financing [...]
 
EQT Life Sciences leads €30M Series C funding round in Onera
Onera Health, a leader in sleep diagnostic and monitoring solutions, closed a €30M ($32M) Series C financing round. The all-equity round was led [...]
 
EQT Life Sciences Co-Leads VectorY’s €129 Million ($138 Million)
  Round co-led by EQT Life Sciences and Forbion    Series A financing will support clinical development of the lead program in [...]
 
EQT LS portfolio company Nouscom Raises €67.5 million ($72 million) in Oversubscr...
New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of [...]
 
EQT Life Sciences invests in $61 Million financing of AstronautX
Amsterdam, The Netherlands, October 16, 2023 - EQT Life Sciences is happy to announce an investment from the LSP Dementia Fund into AstronauTx Lt[...]
 
EQT Life Sciences Leads €54 Million Upsized Financing in MinervaX
EQT Life Sciences leads investment in MinervaX with OrbiMed also joining as a new investor   The financing will advance the development[...]
 
EQT Life Sciences largest investor in Agomab’s USD 100 million Series C financing...
-       EQT Life Sciences invests together with other new investors Fidelity Management & Research Company, Canaan and Dawn Biopharma, a plat[...]
 
EQT Life Sciences closes Dementia Fund at the hard cap
The LSP Dementia Fund has held its final close at approximately EUR 260 million, at the hard cap and above its original target fund size of EUR[...]
 
ImCheck to Present New Positive Data on ICT01 Monotherapy in Hematological Cancers ...
[...]
 
EQT Life Sciences Co-leads $88 Million Series B Financing in QurAlis
Proceeds will advance a pipeline of precision medicines against neurodegenerative diseases. Funding will support the clinical development[...]

2024


EQT Life Sciences leads €30M Series C funding round in Onera
Onera Health, a leader in sleep diagnostic and monitoring solutions, closed a €30M ($32M) Series C financing round. The all-equity round was led by EQT Life Sciences and co-led by Gimv, with existing investors Innov [...]
EQT Life Sciences leads $42M funding round in Phagenesis
Phagenesis, a medical devices company, which specializes in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and co-led by Sectoral Asset Management [...]


2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
back to news overview
Follow us

Archive

HIGHLIGHTS

 
EQT Life Sciences leads $42M funding round in Phagenesis
Phagenesis, a medical devices company, which specializes in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and co-led by Sectoral Asset Management[...]
 
EQT Life Sciences leads €30M Series C funding round in Onera
Onera Health, a leader in sleep diagnostic and monitoring solutions, closed a €30M ($32M) Series C financing round. The all-equity round was led by EQT Life Sciences and co-led by Gimv, with existing investors Innov[...]
 
EQT Life Sciences Co-Leads VectorY’s €129 Million ($138 Million)
  Round co-led by EQT Life Sciences and Forbion    Series A financing will support clinical development of the lead program in amyotrophic lateral sclerosis (ALS) and preclinical development of pip[...]
 
EQT LS portfolio company Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round
New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of its portfolio of neoantigen cancer vaccines to key clinical proof of c[...]
 
EQT Life Sciences invests in $61 Million financing of AstronautX
Amsterdam, The Netherlands, October 16, 2023 - EQT Life Sciences is happy to announce an investment from the LSP Dementia Fund into AstronauTx Ltd. (“AstronauTx” or “the Company”), a UK based biotech compan[...]
 
EQT Life Sciences Leads €54 Million Upsized Financing in MinervaX
EQT Life Sciences leads investment in MinervaX with OrbiMed also joining as a new investor   The financing will advance the development of MinervaX’s maternal vaccine against Group B Streptococcus and he[...]
 
EQT Life Sciences largest investor in Agomab’s USD 100 million Series C financing
-       EQT Life Sciences invests together with other new investors Fidelity Management & Research Company, Canaan and Dawn Biopharma, a platform controlled by KKR   -       Proceeds will support [...]
 
EQT Life Sciences closes Dementia Fund at the hard cap
The LSP Dementia Fund has held its final close at approximately EUR 260 million, at the hard cap and above its original target fund size of EUR 100 million Investors include the Alzheimer’s Association, th[...]
 
ImCheck to Present New Positive Data on ICT01 Monotherapy in Hematological Cancers at ESMO 2023
[...]
 
EQT Life Sciences Co-leads $88 Million Series B Financing in QurAlis
Proceeds will advance a pipeline of precision medicines against neurodegenerative diseases. Funding will support the clinical development of two therapeutic product candidates for ALS.   AMSTERDAM[...]

2024


EQT Life Sciences leads €30M Series C funding round in Onera
Onera Health, a leader in sleep diagnostic and monitoring solutions, closed a €30M ($32M) Series C financing round. The all-equity round was led by EQT Life Sciences and co-led by Gimv, with existing investors Innov [...]
EQT Life Sciences leads $42M funding round in Phagenesis
Phagenesis, a medical devices company, which specializes in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and co-led by Sectoral Asset Management [...]


2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
back to news overview